associations between patterns of alcohol consumption in mid-life (40-59 years) in Alzheimer's cases (n = 179) and healthy controls (n = 284). Cases were recruited from clinical settings and from the community, and controls were friends or neighbors of the cases or members of the same organizations to which cases belonged. Persons with histories of alcoholism were not enrolled in the study. A food frequency questionnaire was used to gather data on servings per day of beer, wine and spirits. Controls responded for themselves and surrogates responded for cases. We have previously shown that this method does not introduce systematic reporting biases in our sample. Results: Of 463 subjects in the study, 146 people reported no alcohol consumption during this age period. Servings of beer ranged from 0 to 5 per day, servings of wine ranged from 0 to 1 per day and servings of spirits ranged from 0 to 4.3 per day. Logistic regression analysis indicated that, adjusting for year of birth, gender and education, consumption of alcoholic beverages in this population during midlife did not increase odds of AD (Odds Ratio 1.076, 95% Confi dence Interval 0.812-1.43). Results were similar when controlling for APOE and the interaction of APOE and mid-life alcohol consumption. Conclusion: Although past research has shown a protective effect of moderate alcohol consumption on cognition, we did not fi nd evidence that alcoholic beverage reduces the odds of AD in this group.
O 3 Glycemic Control and Risk of Dementia in a Cohort of Patients with Type 2 Diabetes
were 25% more likely (HR = 1.25 95% CI 1.03-1.53); and those with levels greater than 15 (n = 105) were 83% more likely (HR = 1.83, 95% CI 1.01-3.65). Conclusion: These results suggest a graded association of higher HbA1c levels with risk for dementia, with a possible threshold at approximately 9.9% Future studies are needed to confi rm that interventions which lower HbA1c lead to lower risk for dementia.
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Tissue-Type Plasminogen Activator -7,351C 1 T Polymorphism, White Matter Lesions, and Lacunar Infarcts D.R. Gustafson, C. Ladenvall, M. Simoni, C. Jern, L. Pantoni, K. Blennow, I. Skoog Florence, Italy; Göteborg, Sweden Purpose: Genes associated with the vascular etiology of agerelated brain changes may provide clues to understanding the neuropathogenesis of Alzheimer's disease (AD) and other dementias. White matter lesions (WML) increase with age and contribute to cognitive decline, motor symptoms and dementia. Tissue-type plasminogen activator (tPA) is produced by endothelial cells, mediates fi brinolysis, and crosses an intact blood-brain barrier. Related to AD, the role of tPA in the brain may be protective and include clot dissolution or amyloid degradation. However, tPA may also be neurotoxic and shift apoptosis in a stressed brain. The t-PA -7,351C 1 T polymorphism (tPA7351) is a new variant related to vascular release of endothelial tPA. We investigated the association between tPA7351 and occurrence of WML in elderly adults. Methods: A population-based, cross-sectional sample of 596 non-demented Swedish women (n = 421) and men (n = 175) who participate in the Gerontological and Geriatric Population Studies (H70) in Göteborg, Sweden were examined using computed tomography (CT), neuropsychiatric, laboratory, and other assessments in 2000. Analysis of tPA7351 was performed in peripheral blood leukocytes. Dementia was diagnosed according to DSM-III-R. The presence of WML and lacunar infarcts was rated via CT. Chi-square and logistic regression analyses were used to evaluate the relationship between tPA7351 and the presence of WML. Results: Conditions for Hardy-Weinberg equilibrium were met. WML were present in 53.3% (58.0% women and 48.6% men) and lacunar infarcts in 46.2% (46.1% women and 46.3% men). The tPA7351CC genotype was related to presence of WML (age-adjusted OR = 1.49, 95% CI 1.07-2.09; multivariate OR = 1.56, 95% CI 1.05-2.33) and lacunar infarcts (age-adjusted OR = 1.45, 95% CI 1.04-2.02; multivariate OR = 1.51, 95% CI 1.07-2.12). These data are potentially in line with recent reports in mouse models that higher levels of tPA in the brain, as suggested by possession of the CC variant, are detrimental for WML and lacunar infarcts. More research is needed on the potential relationship between this tPA-7,351C 1 T gene variant and brain neurotoxicity. tPA7351 may be related to the presence of WML via vascular or neuronal mechanisms. The coding region of the gene is well conserved, but non-coding regions are more variable, most notably a variable number of tandem repeats (VNTR) polymorphism in the 3 untranslated region. We previously identifi ed 22 SNPs covering approximately 5,000 bp 5 of exon 1 through the start of exon 2 (+2,106) which segregated into six common and two rare haplotypes. The six common haplotypes differed signifi cantly in transcriptional activity in a reporter gene assay. Methods: We genotyped 261 incident cases and 376 age-and gender-matched unrelated controls, and inferred haplotypes using the Phase v2.0 program. Common haplotypes categories were combined into the two major clades, as determined by phylogenetic tree analysis. Associations of haplotypes and diplotypes with PD were tested by logistic regression models. Results: We observed a moderate association of one of the major clades with PD (odds ratio [OR] = 1.42; 95% CI: 0.88-2.77). The 3 region VNTR polymorphism was also moderately associated (OR for 9-repeat allele = 1.48; 95% CI: 1.06-2.08). When examined together, frequencies of 5 -3 region diplotypes differed signifi cantly between cases and controls. The odds ratios for being in the intermediate and high risk categories were 1.50 (95% CI: 0.94-2.38) and 2.15 (95% CI: 1.26-3.67), respectively. The association was considerably stronger in the 6 60 age stratum (vs. ! 60). Conclusions: These results indicate that both the 5 and 3 region of the gene affect PD risk, and appear to act in an additive fashion to increase disease risk.
O 6 Primary Prevention of Stroke in Urban Communities in Shanghai, China

Z. Hong, D. Ding, J. Zeng
Shanghai, China
Objective: To evaluate the effectiveness of the comprehensive primary prevention program in urban community in Shanghai. Background: Community-based research is needed in China to validate effective and practical strategies for stroke prevention in primary care. Methods: We randomly selected two communities as the intervention cohort (35,585 population) and the control cohort (47,016 population), respectively. From 1996 to 2000, a comprehensive prevention program of stroke was implemented only in the intervention cohort. The intervention included: Launching the health education and activity in the community for health promotion; Improving the community network of health care; Training Abstracts: Oral Presentations Annual Regional North American Meeting, Neuroepidemiology Research Group, 2006 Neuroepidemiology 2006 26:177-186 182 the local health workers in the community; Strengthening the management for the detection and treatment of hypertension and diabetic patients over 35 years old in the community; introduction of the scientifi c methods to stop smoking. The incidences of stroke in the intervention and control cohorts were under surveillance for fi ve years. We investigated the risk factors due to stroke in both two cohorts at baseline as well as in 2001. The stroke incidences and risk factors were compared between these two cohorts. Results: From 1996 to 2000, the incidences of stroke in the intervention cohort were 162.4, 152.2, 138.1, 143.4 and 130.2 per 100,000 population, respectively. However, the incidences of stroke in the control cohort were 172.3, 173.2, 193.3, 201.0, and 187.4 per 100,000 population, respectively. In the intervention cohort, the levels of total cholesterol (TC) , blood pressure (BP), blood glucose (GLU), body mass index (BMI), and prevalence of smoking decreased in 2000 compared to those in 1997 (p ! 0.05). On the contrary, in the control cohort, the levels of TC, BP, BMI and prevalence of smoking in 2000 were higher than those in 1997 (p ! 0.05). Conclusion: Comprehensive primary prevention appeared to be effective to decrease the incidence of stroke and risk factors in community residence. 
Montevideo, Uruguay
Objective: The purpose of this survey was to determine the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in Uruguay and to analyse the survival of ALS patients. Risk factors were also studied. Background: ALS is a neurodegenerative progressive disease affecting the upper and lower motor neurons. We analysed ALS epidemiologic features in Uruguay, a South American country (35 ° south latitude) with a population composed by European immigrants and a minority of Americans of African origin; there are no native Americans. Methods: A cohort composed by all Uruguayan inhabitants was followed up during two years (1/1/2002-12/31/2003) . Multiple sources of information were used. The revised diagnostic criteria of 'El Escorial' were applied. Clinically defi nite and clinically probable cases of ALS were included. To study risk factors, a case-control survey was performed, including ALS cases and three matched controls. A questionnaire to measure the exposure to different risk factors was applied. Results: 143 cases of ALS were identifi ed, 93 men and 50 women (sex ratio 1.86). The crude prevalence of ALS on December 31 2002, was 1.90 per 100,000 inhabitants (men 2.3; females 1.5). The incidence rate was 1.37/100,000 inhabitants-year (men 1.95; females 0.84). A trend towards increasing age specifi c incidence rates, beginning at about age 30-39 and reaching a peak at age 60-69 was observed. The clinical form more frequently found was spinal amyotrophic (49%). The median of survival time was 44.9 months (95% C.I. 36.1-53.6). An increased risk has been found in rural workers and heavy labour, according to other research studies. Conclusions: Incidence rates and prevalence of ALS in Uruguay are similar to results reported by other surveys. Our results in relation to the epidemiological features are similar to those of previous reports; we suggest that ALS has a uniform pattern under different environmental and geographical conditions.
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Measures and Predictors of Disability in Patients with Amyotrophic Lateral Sclerosis
E. Beghi, G. Logroscino, A. Micheli, A. Millul, E. Vitelli Milano, Lodi and Brescia, Italy; Boston, MA, USA Background: There are virtually no data from populationbased studies on measures and predictors of disability in patients with amyotrophic lateral sclerosis (ALS). Objective: To assess the frequency and predictors of selected disability measures (loss of ambulation, gastrostomy, mechanical ventilation) in a populationbased sample of patients with ALS. Methods: Starting from January 1 1998, 517 patients with newly diagnosed ALS resident of eight administrative districts of Lombardy, a large industrialized area of Northern Italy (population 4,947,554, 2001 census), were included in a population-based registry. Of these, 114 unselected cases (22.1%) were followed for 2,570 person-months (mean 22.5 months). For each patient, data were collected on age, sex, disease duration at diagnosis, type of onset, El-Escorial diagnosis (chosen as predictors of disability). During follow-up, the cumulative timedependent risk of wheel-chair, gastrostomy, and mechanical ventilation was estimated according to the Kaplan-Meier method. The predictors of disability were assessed by multivariate analysis with the Cox's proportional hazard function. Results: During follow-up, 29 patients (25.4%) became wheel-chair bound, 51 (44.7%) received gastrostomy, and 47 (41.2%) were ventilated mechanically. The median time to loss of ambulation was 46.7 months (95% CI 36.5-56.8). The corresponding times to gastrostomy and mechanical ventilation were 31.1 months (95% CI 26.8-35.4) and 34.6 months (95% CI 29.6-39.6). Spinal-onset ALS was the only independent predictor of loss of ambulation. Independent predictors of gastrostomy were older age, defi nite ALS (El-Escorial), and shorter disease duration at diagnosis. Shorter disease duration at diagnosis was the only independent predictor of mechanical ventilation. Conclusion: Loss of ambulation, gastrostomy and mechanical ventilation are frequent indices of disability in ALS. However, patients differ in terms of measures and predictors of disability, suggesting that ALS is a heterogeneous clinical condition. These factors must be considered as sources of bias and confounding in randomized clinical trials. Objective: To describe the design and follow-up of a newly established oophorectomy cohort study. Background: The effect of endogenous estrogen on aging remains uncertain. Methods: We constructed a historical cohort of all 2,511 women who underwent oophorectomy before menopause in Olmsted County, MN between 1950 and 1987 (oophorectomy cohort). We also matched each woman with oophorectomy to a woman of the same age from the same population who was free of oophorectomy (referent cohort). Follow-up was both active (interviews and exams) and passive through the medical records-linkage system of the Rochester Epidemiology Project. Results: Bilateral oophorectomy was elective in 540 women (44.7%), due to cancer in 112 (9.3%), and due to other indications in 557 (46.1%). Unilateral oophorectomy was elective in 339 women (26.0%), due to cancer in 9 (0.7%), to a cyst in 318 (24.4%), to endometriosis in 208 (16.0%), and to other indications in 428 (32.9%). Bilateral oophorectomies occurred at a signifi cantly older age than unilateral oophorectomies (median 46.0 vs. 37.6 years; p ! 0.0001) and were more frequently in conjunction with a complete abdominal hysterectomy (91.8%) than unilateral oophorectomy (64.4%; p ! 0.0001). Of 2,511 women with oophorectomy, 2,244 (89.4%) had adequate follow-up; they were studied actively through direct interview (1,110; 49.5%) or proxy interview (468; 20.8%), or passively through medical records abstracting (666; 29.7%). Only 267 (10.6%) had incomplete follow-up. Of 2,511 referent women, 2,188 (87.1%) had adequate follow-up; they were studied actively through direct interview (1,080; 49.4%) or proxy interview (478; 21.8%), or passively through medical records abstracting (630; 28.8%). Only 323 (12.9%) had incomplete follow-up. Conclusions: This newly established historical cohort study provides opportunities to test hypotheses regarding the link between endogenous estrogen and overall mortality, aging, and aging-related neurological diseases.
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Association of Dopaminergic Receptor (DRD2) Genetic Variants with Parkinson's Disease
V. McGuire, S. Van Den Eeden, C. Tanner, H. Tabor, B. Topol, A. Southwick, R. Popat, R. Myers, L. Nelson Stanford, CA, Oakland, CA, and Sunnyvale, CA, USA Objective: To examine the genetic association of polymorphisms in the dopamine receptor D2 (DRD2) gene with the risk of Parkinson's disease (PD). Background: DRD2 is a polymorphic gene that has been associated with the initiation and persistence of cigarette smoking, and in some studies, with Parkinson's disease. Methods: The study population included 403 newly diagnosed patients with PD identifi ed within Kaiser Permanente Northern California health maintenance organization during the years 1994-1995, and 453 age-and gender-matched controls from the same population. Demographic and risk factor information were collected by in-person structured interview. DNA sequencing of 24 earlyonset PD cases was used to identify single nucleotide polymorphisms (SNPs) of DRD2. Genotyping assays for four SNPs most likely to affect protein function were carried out for all cases and controls. Odds ratios were estimated using logistic regression with adjustment for age, gender and race/ethnicity. Results: Only one polymorphic variant, in the 5 transcription region, was associated with PD. In the non-Hispanic Caucasian group, the risk for PD was higher among individuals who were homozygous for the variant allele (17% of cases; 12% of controls; OR = 1.6, 95% CI 1.05-2.6) than for the heterozygotes (49% of cases; 46% of controls; OR = 1.3, 95% CI 0.92-1.7); p for trend = 0.02. Interestingly, this variant was not associated with PD risk among never smokers, but was significantly associated with PD in a dose-response trend among cigarette smokers (heterozygotes OR = 1.3, 95% CI 0.84-2.0; homozygotes OR = 1.7, 95% CI 0.98-2.9; p for trend = 0.05). Conclusion: This study provides evidence that the association of a regulatory SNP of DRD2 with Parkinson's disease varies by cigarette smoking status. The pathophysiologic signifi cance of this fi nding needs elucidation. Objective: The aim of this study was to evaluate anger trait in patients with Parkinson's disease (PD). Background: Cognitivepsychiatric features of PD may be as disabling as the motor features of the disease. The personality profi le of patients with PD is characterized by a number of traits. Stoic and infl exible personality traits have been linked with PD. A systematic study of anger trait in PD has not been performed. Method: We characterized anger trait in a clinic series of 126 PD patients and in 126 age-and gender-matched healthy controls using the Spanish adapted version of the State-Trait Anger Expression Inventory-2 (STAXI-2). Results: Signifi cant changes on multiple dimensions of the STAXI were observed, including Trait Anger, 19.2 8 5.3 in cases vs. 20.7 8 6 in controls, p = 0.04; Angry Temperament, 7.4 8 2.7 in cases vs. 8.8 8 3.5 in controls p = 0.001; Anger Expression-Out, 9.0 8 2.5 in cases vs. 10.5 8 3.0 in controls, p ! 0.001; Anger Expression-In, 14.0 8 3.4 in cases vs. 12.2 8 3.2 in controls, p ! 0.001; Anger Control-Out, 18.6 8 5.0 in cases vs. 16.1 8 5.0 in controls, p ! 0.001; and Anger Control-In, 14.3 8 4.7 in cases vs. 13.0 8 4.5 in controls, p = 0.028. In linear regression models that controlled for age, gender, and disease duration, scores on different anger dimensions were related to disease-related disability (assessed using the Hoehn & Yahr scale). Conclusions: PD patients showed lower levels of external expression of anger and higher levels of internal Abstracts: Poster Presentations Annual Regional North American Meeting, Neuroepidemiology Research Group, 2006 Neuroepidemiology 2006 26:177-186 184 and external control of anger. Furthermore, these changes in PD were associated with the level of disability. Our results demonstrate another dimension to the stoic personality trait seen in PD. Furthermore, these fi ndings extend the range of psychiatric-cognitive problems observed in this complex disorder.
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Parkscreen: Assessing Familial Parkinsonism in Isolated Populations M. Facheris, C. Beu Volpato, A. De Grandi, I. Pichler, F. Marroni, P. Pramstaller 
Bolzano, Italy
Objective: To assess the frequency, distribution and genetic characteristics of familial parkinsonisms in South Tyrol, and to elucidate PD molecular mechanisms by using a validated threestage ascertainment method along with a new genetic screening tool. Background: Several forms of familial parkinsonisms have been recently studied and causal genes have been discovered. Isolated populations, characterized by reduced genetic and environmental diversity, represent an exceptional resource for gene mapping studies. Large parts of the German-and Ladin-speaking population of South Tyrol (northern Italy) can be considered isolated populations, giving ideal conditions for linkage studies and genegene, gene-environment interactions. Methods: First, we will mail a sensitive (95%) and specifi c (89%) questionnaire, validated in two languages (German and Italian), to individuals 18 y/o and older followed by 15 large primary care practices to select people with parkinsonism. Second, people who screen positive to the questionnaire will be visited by the specifi cally trained primary care physician to have a second stage diagnosis, and to draw genealogical trees by a family history tool. Finally, defi nitive diagnosis and classifi cation of parkinsonism will be made by a movement disorder specialist (three-stage ascertainment method). Blood will be drawn to extract DNA: 42 polymorphic markers surrounding loci to date involved in PD (PARK1-PARK11, MAPT, NR4A2, NDUFV2) have been selected corresponding to the different models of disease inheritance. Markers have been chosen according to their highest heterogeneity and to the integrated physical human genomics databases. Conclusions: This three-stage ascertainment method along with our new genetic screening tool is easily applicable to familial PD and to all genetically homogenous populations. It allows in a very short time and at low cost: (i) the identifi cation of new PD groups with the same genetic alteration, (ii) the discovery of new loci or genes involved in PD pathogenesis, and (iii) the elucidation of interactions between loci and/or genes. 
Göteborg, Sweden
Objective: To study dementia prevalence in extreme old age. Background: Dementia increases with age, with a doubling of the prevalence every 5 years up to age 90. Above this age most studies include few individuals and the fi gures are therefore uncertain. Methods: The 95+ Study is an ongoing study of the oldest-old in Göteborg, Sweden. All individuals registered for census and born between 1901 and 1908 were invited to participate in the study. The response rate was 70%, and there was no difference in mortality between participants and refusals. The current analysis was based on 1,147 examinations at ages 95-101 years. All participants were examined with a comprehensive neuropsychiatric examination and a cognitive test battery. Dementia was diagnosed according to DSM-III-R criteria. Results: The prevalence of dementia was 51% at age 95 (n = 338), 54% at age 97 (n = 491), 63% at age 99 (n = 187), 66% at age 100 (n = 94) and 70% at age 101 (n = 37) (preliminary data presented from age 97 and above). Conclusion: The prevalence of dementia continues to increase after age 95. (Folstein, 1975 ) is however largely used for detecting dementia and prescribing cholinesterase inhibitors agents. The need of a brief and valid instrument constitutes up till now the main purpose of many studies. Since MMSE, many variants have been proposed: 3MS, SMMSE, K-mMMSE, TE4D-Cog. TMMS-90 is scored on 90 and includes, besides MMSE orientation and language items, new item sets assessing working memory, episodic long term memory (recall and recognition), semantic memory, executive functions and constructive praxis. Methods: 88 subjects, attending our Memory outpatient clinic, have received a complete neurological exam (including CDR), a neuropsychological testing of major cognitive and conative functions, and at least a CT scan, MRI or SPECT imaging. Cut-off, for suspected or abnormal scores, has been established according to education level for MMSE and to age and education level for TMMS-90. Results: TMMS-90 Cronbach's alpha is equal to 0.91 whereas MMSE alpha = 0.74. Adding to MMSE items, TMMS-90 working memory, recognition and executive functions items, alpha becomes equal to 0.88, revealing MMSE limits. MMSE sensitivity is equal to 86%, specifi city = 43% and kappa = 0.28. TMMS-90 overall score sensitivity is equal to 59%, specifi city = 100% and kappa = 0.31. Further, TMMS-90 scatter (according to subtests results) allows distinguishing different cognitive profi le types (Alzheimer, FTD, LBD... MCI or Normal) with a sensitivity equal to 95%, specifi city = 50% and kappa = 0.49. Conclusion: TMMS-90 is more relevant than MMSE for screening dementia in Tunisia. Combining overall TMMS-90 score to its scatter analysis, allows effi cient detection of early stages and type of dementia. However, TMMS-90 overall score sensitivity must be enhanced.
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MSCQoL questionnaire (data quality, scaling assumptions, acceptability, reliability and validity) will be examined.
Conclusions:
The MSCQoL questionnaire will provide a new tool to further determine the impact of the illness. The instrument may be used to augment existing clinical assessments that assess the effi cacy of potentially therapeutic agents for MS.
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Midlife Respiratory Function Related to White Matter Lesions and Lacunar Infarcts in Late Life
